Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
Improved functionality across four valve sizes and lowest delivery profile on market, Evolut PRO+ TAVR System launches in U.S. as TAVR patient population grows.
Changing regulations and new demands from medical device manufacturers are causing packaging and sterilization suppliers to revise and update their offerings.